TITLE:
A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)

CONDITION:
Gastrointestinal Stromal Tumor

INTERVENTION:
Placebo

SUMMARY:

      A study to assess the safety and efficacy of SU11248 in patients with gastrointestinal
      stromal tumor (GIST) whose disease has failed imatinib therapy or who were intolerant to
      imatinib treatment.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Key Inclusion Criteria:

          -  Histologically-proven diagnosis of malignant GIST not amenable to surgery, radiation
             or combined modality treatment with curative intent

          -  Failed Gleevec treatment or intolerant to Gleevec therapy

        Key Exclusion Criteria:

          -  Treatment with any chemotherapy, chemoembolization therapy, immunotherapy, or
             investigational agent since the last dose of Gleevec
      
